Literature DB >> 21318235

Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.

Ana P Guimarães1, Aline A Oliveira, Elaine F F da Cunha, Teodorico C Ramalho, Tanos C C França.   

Abstract

As the enzyme nucleoside hydrolase (NH) is widely found in nature but has not yet been detected in mammals, it is considered an ideal target in the development of chemotherapy against parasitic diseases and bacterial infections like anthrax. Considering the risk that this biological warfare agent represents nowadays, the search for new drugs and new molecular targets in the development of chemotherapy against anthrax is imperative. On this basis, we performed docking studies of six known NH inhibitors at the active site of NH from Bacillus anthracis (BaNH). Subsequently, molecular dynamics (MD) simulations of these compounds inside BaNH were carried out in order to complement the docking studies and select the most promising compounds as leads for the design of potential BaNH inhibitors. Most of the docking and MD results obtained agreed well with each other and showed good correlation with experimental data.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318235     DOI: 10.1007/s00894-011-0968-9

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  31 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The RihA, RihB, and RihC ribonucleoside hydrolases of Escherichia coli. Substrate specificity, gene expression, and regulation.

Authors:  C Petersen; L B Møller
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.

Authors:  W Versées; J Barlow; J Steyaert
Journal:  J Mol Biol       Date:  2006-03-29       Impact factor: 5.469

Review 4.  Catalysis by nucleoside hydrolases.

Authors:  Wim Versées; Jan Steyaert
Journal:  Curr Opin Struct Biol       Date:  2003-12       Impact factor: 6.809

5.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

6.  A critical assessment of docking programs and scoring functions.

Authors:  Gregory L Warren; C Webster Andrews; Anna-Maria Capelli; Brian Clarke; Judith LaLonde; Millard H Lambert; Mika Lindvall; Neysa Nevins; Simon F Semus; Stefan Senger; Giovanna Tedesco; Ian D Wall; James M Woolven; Catherine E Peishoff; Martha S Head
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

7.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

8.  Distribution and economic importance of anthrax.

Authors:  M Sterne
Journal:  Fed Proc       Date:  1967-09

9.  N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.

Authors:  Annelies Goeminne; Maya Berg; Michael McNaughton; Gunther Bal; Georgiana Surpateanu; Pieter Van der Veken; Stijn De Prol; Wim Versées; Jan Steyaert; Achiel Haemers; Koen Augustyns
Journal:  Bioorg Med Chem       Date:  2008-06-18       Impact factor: 3.641

10.  The URH1 uridine ribohydrolase of Saccharomyces cerevisiae.

Authors:  Jean-Emmanuel Kurtz; Françoise Exinger; Philippe Erbs; Richard Jund
Journal:  Curr Genet       Date:  2002-06-12       Impact factor: 3.886

View more
  8 in total

1.  Structural explanation for the tunable substrate specificity of an E. coli nucleoside hydrolase: insights from molecular dynamics simulations.

Authors:  Stefan A P Lenz; Stacey D Wetmore
Journal:  J Comput Aided Mol Des       Date:  2018-11-26       Impact factor: 3.686

2.  Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats.

Authors:  Ming Li; Dianbin Yang; Lu Mei; Lin Yuan; Ao Xie; Jieli Yuan
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

3.  Microecological treatment of hyperuricemia using Lactobacillus from pickles.

Authors:  Yuanxun Xiao; Congxin Zhang; Xianli Zeng; Zhichao Yuan
Journal:  BMC Microbiol       Date:  2020-07-06       Impact factor: 3.605

4.  Molecular modeling studies on the interactions of 7-methoxytacrine-4-pyridinealdoxime, 4-PA, 2-PAM, and obidoxime with VX-inhibited human acetylcholinesterase: a near attack conformation approach.

Authors:  Jorge Alberto Valle da Silva; Eugenie Nepovimova; Teodorico Castro Ramalho; Kamil Kuca; Tanos Celmar Costa França
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 5.  Structure, Oligomerization and Activity Modulation in N-Ribohydrolases.

Authors:  Massimo Degano
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  Theoretical Studies Applied to the Evaluation of the DFPase Bioremediation Potential against Chemical Warfare Agents Intoxication.

Authors:  Flávia V Soares; Alexandre A de Castro; Ander F Pereira; Daniel H S Leal; Daiana T Mancini; Ondrej Krejcar; Teodorico C Ramalho; Elaine F F da Cunha; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

7.  Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3).

Authors:  Madhu Sudhana Saddala; Pradeepkiran Jangampalli Adi
Journal:  Heliyon       Date:  2018-05-08

8.  Understanding the Interaction Modes and Reactivity of Trimedoxime toward MmAChE Inhibited by Nerve Agents: Theoretical and Experimental Aspects.

Authors:  Alexandre A de Castro; Daniel A Polisel; Bruna T L Pereira; Elaine F F da Cunha; Kamil Kuca; Eugenie Nepovimova; Teodorico C Ramalho
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.